Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CellaVision is a global leader in digital morphology, developing automated systems for blood and body fluid analysis. Their innovative solutions optimize laboratory automation, enhancing efficiency and quality in hematology and clinical microbiology labs through advanced image analysis and diagnostics.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CellaVision is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CellaVision last reported quarterly earnings on 7/17/2026 (Q2 2026). Earnings per share (EPS) came in at 1.37 SEK.
Across its last 5 earnings reports, CellaVision stock moved by ±11.5% on average the following day. The largest reaction was -21.5% on 04/24/2026; 2 of 5 reactions were positive.
CellaVision has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.